Tissue transglutaminase-serology markers for coeliac disease

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 5, 2002, Pages 485-492

  Kocna, Petr ^a   Vaníčková, Zdislava ^a   Perušičová, Jindřiška ^a   Dvořák, Miloš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anti tissue transglutaminase; Autoimmunity; Coeliac disease; Diabetes mellitus; Serological markers

Indexed keywords

AUTOANTIGEN; BIOLOGICAL MARKER; ENDOMYSIUM ANTIBODY; ENZYME ANTIBODY; GLIADIN ANTIBODY; GLUTAMATE DEHYDROGENASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT ANTIGEN; ANTIBODY; DIAGNOSTIC AGENT; GLIADIN; IMMUNOGLOBULIN CLASS;

ADULT; ALGORITHM; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; ANALYTICAL EQUIPMENT; ANIMAL; BLOOD; COMPARATIVE STUDY; GUINEA PIG; IMMUNOLOGY; MASS SCREENING; STANDARD;

ADULT; ALGORITHMS; ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; CELIAC DISEASE; FEMALE; GLIADIN; GUINEA PIGS; HUMANS; IMMUNOGLOBULIN ISOTYPES; MALE; MASS SCREENING; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRANSGLUTAMINASES;

EID: 0036294678     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.084     Document Type: Article

References (50)

1. High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies
2. Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors
3. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope
4. Isolation and analysis of peptidic fragments of alpha-gliadin using reversed-phase high-performance liquid chromatography
5. Relationship between gliadin peptide structure and their effect on the fetal chick duodenum
6. The activity of single gliadin components in a foetal chick intestine assay for coeliac disease
7. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope
8. Identification of tissue transglutaminase as the autoantigen of celiac disease
9. Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase
10. Celiac disease-associated autoimmune endocrinopathies
11. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice
12. The widening spectrum of celiac disease
13. Malignancy in coeliac disease - Effect of a gluten free diet
14. Malignancy in coeliac disease and dermatitis herpetiformis
15. Gluten-free diet prevents diabetes in NOD mice
16. Revised criteria for diagnosis of coeliac disease
17. Molecular mimicry as a possible cause of autoimmune reactions in celiac disease? Antibodies to gliadin cross-react with epitopes on enterocytes
18. Anti-gliadin antibodies in patients with celiac disease cross-react with enterocytes and human calreticulin
19. Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases
20. Simple starch-gel electrophoresis of gliadin proteins using the LKB-Multiphor system
21. Celiac disease: The past, present, the future
22. Comparative evaluation of serologic tests for celiac disease: A European initiative toward standardization
23. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients
24. Coeliac disease diagnostic with antigliadin, antiendomysium and antitransglutaminase antibodies
25. Serological markers for coeliac disease: Is it time to change?
26. Diagnostic approach to a patient with suspected celiac disease: A cost analysis
27. Correlation between tissue transglutaminase antibodies and endomysium antibodies as diagnostic markers of coeliac disease
28. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis
29. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice
30. IgA antibodies against endomysium and transglutaminase: A comparison of methods
31. Anti-endomysial antibody negative celiac disease: Does additional serological testing help?
32. Identification of a new coeliac disease subgroup: Antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency
33. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency
34. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy
35. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy
36. Human recombinant tissue transglutaminase ELISA: An innovative diagnostic assay for celiac disease
37. Anti-transglutaminase IgA ELISA: Clinical potential and drawbacks in celiac disease diagnosis
38. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease
39. Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease
40. Development of a novel rapid non-invasive screening test for coeliac disease
41. Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing
42. The measurement of IgA and IgG transglutaminase antibodies in celiac disease: A comparison with current diagnostic methods
43. Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: Evidence for high diagnostic sensitivity for celiac disease
44. Celiac disease-associated autoimmune endocrinopathies
45. Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects
46. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase
47. Development of celiac disease-associated antibodies in offspring of parents with type 1 diabetes
48. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with type 1 diabetes mellitus
49. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies
50. Coeliac disease and type 1 diabetes mellitus -the case for screening